AIM ImmunoTech AIM will release its quarterly earnings report on Friday, 2024-11-15. Here’s a brief overview for investors ahead of the announcement.
Analysts anticipate AIM ImmunoTech to report an earnings per share (EPS) of $-0.09.
Anticipation surrounds AIM ImmunoTech’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings Track Record
During the last quarter, the company reported an EPS beat by $0.09, leading to a 5.88% increase in the share price on the subsequent day.
Here’s a look at AIM ImmunoTech’s past performance and the resulting price change:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.09 | -0.12 | -0.11 | -0.15 |
| EPS Actual | -0.06 | -0.03 | -0.12 | -0.26 |
| Price Change % | -12.0% | 6.0% | 3.0% | 6.0% |
Performance of AIM ImmunoTech Shares
Shares of AIM ImmunoTech were trading at $0.129701 as of March 26. Over the last 52-week period, shares are down 73.07%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for AIM ImmunoTech visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
